Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025-06 · 1871 (5) · 167809
DOI: 10.1016/j.bbadis.2025.167809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025-06. Verfasst von Nattayaporn Apaijai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand;…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Cognitive Dysfunction, Myocardial Infarction, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Chiang Mai University Faculty of Medicine, Chiang Mai University, National Research Council of Thailand.
Abstract (Originalsprache)
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are recommended to treat heart failure (HF) with the benefit of mitigating cognitive impairment in HF patients with type 2 diabetes. However, the underlying mechanisms are still unclear. This study aimed to investigate whether SGLT2i can improve cognitive function and synaptic plasticity in rats with myocardial infarction (MI) through attenuating inflammation, oxidative stress, impaired metabolism, and mitochondrial dysfunction in the brain. Male rats (n = 8/group) underwent either a sham operation or MI induced by permanent ligation of the left anterior descending coronary artery. MI rats with ejection fraction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Ma…
- Research Administration Section, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Förderung
- Chiang Mai University Faculty of Medicine
- Chiang Mai University
- National Research Council of Thailand
Zitieren
APA
Apaijai, N., Attachaipanich, T., Maneechote, C., Pintana, H., Thonusin, C., Chunchai, T., Pantiya, P., Arunsak, B., Kongkaew, A., Chattipakorn, N., & Chattipakorn, S. C. (2025). Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1871(5), 167809. https://doi.org/10.1016/j.bbadis.2025.167809
Vancouver
Apaijai N, Attachaipanich T, Maneechote C, Pintana H, Thonusin C, Chunchai T, et al. Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871(5):167809. doi:10.1016/j.bbadis.2025.167809
BibTeX
@article{Apaijai2025,
author = {Apaijai, Nattayaporn and Attachaipanich, Tanawat and Maneechote, Chayodom and Pintana, Hiranya and Thonusin, Chanisa and Chunchai, Titikorn and Pantiya, Patcharapong and Arunsak, Busarin and Kongkaew, Aphisek and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
title = {Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
volume = {1871},
number = {5},
pages = {167809},
doi = {10.1016/j.bbadis.2025.167809}
}
EUVIMED